These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 2982002)

  • 1. Notification of a cohort of workers at risk of bladder cancer.
    Schulte PA; Ringen K; Altekruse EB; Gullen WH; Davidson K; Anderson SS; Patton MG
    J Occup Med; 1985 Jan; 27(1):19-28. PubMed ID: 2982002
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term impact of worker notification: qualitative assessment of a community-based notification and screening program in Augusta, Georgia.
    Needleman C; Connally LB
    Am J Ind Med; 2003 Aug; 44(2):113-23. PubMed ID: 12874843
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Notification and risk assessment for bladder cancer of a cohort exposed to aromatic amines. III. Mortality among workers exposed to aromatic amines in the last beta-naphthylamine manufacturing facility in the United States.
    Stern FB; Murthy LI; Beaumont JJ; Schulte PA; Halperin WE
    J Occup Med; 1985 Jul; 27(7):495-500. PubMed ID: 4032086
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Occupational hazards and bladder cancer].
    Nizamova RS
    Urol Nefrol (Mosk); 1991; (5):35-8. PubMed ID: 1836689
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bladder cancer risks in workers manufacturing chemicals for the rubber industry.
    Sorahan T
    Occup Med (Lond); 2008 Oct; 58(7):496-501. PubMed ID: 18725381
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Problems in notification and screening of workers at high risk of disease.
    Schulte PA
    J Occup Med; 1986 Oct; 28(10):951-7. PubMed ID: 3772551
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of a national register on occupational exposure to carcinogens: effectiveness in the prevention of occupational cancer, and cancer risks among the exposed workers.
    Kauppinen T; Saalo A; Pukkala E; Virtanen S; Karjalainen A; Vuorela R
    Ann Occup Hyg; 2007 Jul; 51(5):463-70. PubMed ID: 17625219
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bladder cancer among chemical workers exposed to nitrogen products and other substances.
    Marsh GM; Gula MJ; Youk AO; Cassidy LD
    Am J Ind Med; 2002 Oct; 42(4):286-95. PubMed ID: 12271476
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NIOSH alert: request for assistance in preventing bladder cancer from exposure to o-toluidine and aniline.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1991 May; 40(21):353-4. PubMed ID: 2034200
    [No Abstract]   [Full Text] [Related]  

  • 10. Preventing bladder cancer from exposure to o-toluidine and aniline.
    Am Ind Hyg Assoc J; 1991 May; 52(5):A260, A262. PubMed ID: 1951057
    [No Abstract]   [Full Text] [Related]  

  • 11. Cancer mortality and incidence among a cohort of benzidine and dichlorobenzidine dye manufacturing workers.
    Rosenman KD; Reilly MJ
    Am J Ind Med; 2004 Nov; 46(5):505-12. PubMed ID: 15490466
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Field molecular epidemiology. Feasibility of monitoring for the malignant bladder cell phenotype in a benzidine-exposed occupational cohort.
    Bi W; Rao JY; Hemstreet GP; Fang P; Asal NR; Zang M; Min KW; Ma Z; Lee E; Li G
    J Occup Med; 1993 Jan; 35(1):20-7. PubMed ID: 7678643
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Occupational bladder cancer.
    Tepper LB
    J Ky Med Assoc; 1974 Mar; 72(3):135-8. PubMed ID: 4815653
    [No Abstract]   [Full Text] [Related]  

  • 14. [Clinical problems in patients who were exposed to carcinogens].
    Kotake T
    Hinyokika Kiyo; 1989 Dec; 35(12):2063-7. PubMed ID: 2618906
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Social dimensions of the health hazard evaluation: a case study.
    Quinn MM; Levenstein C
    J Public Health Policy; 1987; 8(2):192-201. PubMed ID: 2821068
    [No Abstract]   [Full Text] [Related]  

  • 16. Framework provides path through right-to-know law.
    Ashford NA; Caldart CC
    Occup Health Saf; 1983 Oct; 52(10):11-9, 25-7. PubMed ID: 6646543
    [No Abstract]   [Full Text] [Related]  

  • 17. Bladder cancer screening and monitoring of 4,4'-methylenebis(2-chloroaniline) exposure among workers in Taiwan.
    Chen HI; Liou SH; Loh CH; Uang SN; Yu YC; Shih TS
    Urology; 2005 Aug; 66(2):305-10. PubMed ID: 16098360
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The glutathione S-transferase M1 (GSTM1) null genotype and benzidine-associated bladder cancer, urine mutagenicity, and exfoliated urothelial cell DNA adducts.
    Rothman N; Hayes RB; Zenser TV; DeMarini DM; Bi W; Hirvonen A; Talaska G; Bhatnagar VK; Caporaso NE; Brooks LR; Lakshmi VM; Feng P; Kashyap SK; You X; Eischen BT; Kashyap R; Shelton ML; Hsu FF; Jaeger M; Parikh DJ; Davis BB; Yin S; Bell DA
    Cancer Epidemiol Biomarkers Prev; 1996 Dec; 5(12):979-83. PubMed ID: 8959320
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Use of pension records for occupational health surveillance: example of record-linkage with hospital discharge records to study the association between work and the incidence of leukaemias, lung and bladder cancer, and miscarriage].
    d'Errico A; Mamo C; Costa G; Filippi M; Crosignani P
    Med Lav; 2005; 96 Suppl():s147-60. PubMed ID: 15871626
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Occupational exposure and bladder cancer].
    Conso F
    Rev Prat; 2004 Oct; 54(15):1665-70. PubMed ID: 15605580
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.